Literature DB >> 10473483

Morphine induced allodynia in a child with brain tumour.

S Heger1, C Maier, K Otter, U Helwig, M Suttorp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10473483      PMCID： PMC1116494          DOI： 10.1136/bmj.319.7210.627

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

1.  Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo.

Authors:  T Warncke; A Stubhaug; E Jørum
Journal:  Pain       Date:  1997-08       Impact factor: 6.961

Review 2.  Long-term opioid therapy: assessment of consequences and risks.

Authors:  S R Savage
Journal:  J Pain Symptom Manage       Date:  1996-05       Impact factor: 3.612

Review 3.  Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions.

Authors:  Jianren Mao; Donald D Price; David J Mayer
Journal:  Pain       Date:  1995-09       Impact factor: 6.961

4.  Paradoxical pain.

Authors:  D Bowsher
Journal:  BMJ       Date:  1993-02-20

Review 5.  Morphine metabolites.

Authors:  L L Christrup
Journal:  Acta Anaesthesiol Scand       Date:  1997-01       Impact factor: 2.105

6.  Morphine-3-glucuronide: evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat.

Authors:  Gregg D Smith; Maree T Smith
Journal:  Pain       Date:  1995-07       Impact factor: 6.961

7.  Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists.

Authors:  Per Sjøgren; Niels-Henrik Jensen; Troels Staehelin Jensen
Journal:  Pain       Date:  1994-11       Impact factor: 6.961

8.  Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories.

Authors:  P Sjøgren; L P Thunedborg; L Christrup; S H Hansen; J Franks
Journal:  Acta Anaesthesiol Scand       Date:  1998-10       Impact factor: 2.105

9.  Morphine metabolism in neonates and infants.

Authors:  I Choonara; A Lawrence; A Michalkiewicz; A Bowhay; J Ratcliffe
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

10.  Kinetics of morphine in patients with renal failure.

Authors:  J Säwe; I Odar-Cederlöf
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953
View more
  6 in total

1.  Morphine induced allodynia in child with brain tumour. Signs are more likely to have been due to underlying medical condition.

Authors:  I L Marples; P Murray
Journal:  BMJ       Date:  2000-02-05

Review 2.  Postoperative pain management in children and infants: an update.

Authors:  Christopher Brasher; Benjamin Gafsous; Sophie Dugue; Anne Thiollier; Joelle Kinderf; Yves Nivoche; Robert Grace; Souhayl Dahmani
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

Review 3.  Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations.

Authors:  Caroline A Arout; Ellen Edens; Ismene L Petrakis; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749

4.  [Dependency syndrome and hyperalgesia due to an opioid therapy for curative treatable pain. Case report of an apparent palliative patient].

Authors:  B Michel-Lauter; K Bernardy; A Schwarzer; V Nicolas; C Maier
Journal:  Schmerz       Date:  2013-09       Impact factor: 1.107

5.  Altered quantitative sensory testing outcome in subjects with opioid therapy.

Authors:  Lucy Chen; Charlene Malarick; Lindsey Seefeld; Shuxing Wang; Mary Houghton; Jianren Mao
Journal:  Pain       Date:  2009-02-23       Impact factor: 6.961

Review 6.  Pediatric palliative care: use of opioids for the management of pain.

Authors:  Boris Zernikow; Erik Michel; Finella Craig; Brian J Anderson
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.